Literature DB >> 24508318

Avian influenza A H10N8--a virus on the verge?

Adolfo García-Sastre1, Mirco Schmolke2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24508318     DOI： 10.1016/S0140-6736(14)60163-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza Virus.

Authors:  Netanel Tzarum; Robert P de Vries; Wenjie Peng; Andrew J Thompson; Kim M Bouwman; Ryan McBride; Wenli Yu; Xueyong Zhu; Monique H Verheije; James C Paulson; Ian A Wilson
Journal:  Cell Rep       Date:  2017-04-11       Impact factor: 9.423

2.  Unique Structural Features of Influenza Virus H15 Hemagglutinin.

Authors:  Netanel Tzarum; Ryan McBride; Corwin M Nycholat; Wenjie Peng; James C Paulson; Ian A Wilson
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

Review 3.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

4.  Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.

Authors:  Teddy John Wohlbold; Veronika Chromikova; Gene S Tan; Philip Meade; Fatima Amanat; Phillip Comella; Ariana Hirsh; Florian Krammer
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

5.  High Pathogenicity of Influenza A (H10N8) Virus in Mice.

Authors:  Haiying Chen; Lihong Huang; Hui Li; Xianfeng Zhou; Huanan Li; Na Sun; Wenbao Qi; Chencheng Xiao; Xiansheng Ni; Mingbin Liu; Ming Liao
Journal:  Am J Trop Med Hyg       Date:  2015-09-08       Impact factor: 2.345

6.  Identification of the source of A (H10N8) virus causing human infection.

Authors:  Yifei Xu; Huabin Cao; Hongyan Liu; Hailiang Sun; Brigitte Martin; Yulong Zhao; Qi Wang; Guangfu Deng; Jianli Xue; Yibo Zong; Jing Zhu; Feng Wen; Li-Ping Long; Sook-San Wong; Nan Zhao; Xiaoshan Fu; Ming Liao; Guoliang Hu; Richard Webby; George F Gao; Xiu-Feng Wan
Journal:  Infect Genet Evol       Date:  2014-12-27       Impact factor: 3.342

7.  Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.

Authors:  Gerald Aichinger; Barbara Grohmann-Izay; Maikel V W van der Velden; Sandor Fritsch; Manuela Koska; Daniel Portsmouth; Mary Kate Hart; Wael El-Amin; Otfried Kistner; P Noel Barrett
Journal:  Clin Vaccine Immunol       Date:  2014-10-29

8.  A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors.

Authors:  Heng Zhang; Robert P de Vries; Netanel Tzarum; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

9.  Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.

Authors:  Peter Pushko; Xiangjie Sun; Irina Tretyakova; Rachmat Hidajat; Joanna A Pulit-Penaloza; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  Vaccine       Date:  2016-09-20       Impact factor: 3.641

10.  Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.

Authors:  Irina Tretyakova; Rachmat Hidajat; Garrett Hamilton; Noah Horn; Brian Nickols; Raphael O Prather; Terrence M Tumpey; Peter Pushko
Journal:  Virology       Date:  2015-11-02       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.